
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 International Agency for Research on Cancer, Lyon, France; 2 Department of Epidemiology, University of California at Los Angeles, Los Angeles, California; Institutes of 3 Occupational Health and 4 Hygiene, University of Brescia, Brescia, Italy; 5 German Cancer Research Center, Heidelberg, Germany; and 6 Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California
Requests for reprints: Rayjean J. Hung, Internal Agency for Research on Cancer Epidemiology, 150 cours Albert-Thomas, 69008 Lyon, France. Fax: 33-4-72738320. E-mail: hung{at}iarc.fr
Background: Genetic association studies are generating much information, usually in the form of single nucleotide polymorphisms in candidate genes. Analyzing such data is challenging, and raises issues of multiple comparisons and potential false-positive associations. Using data from a case-control study of bladder cancer, we showed how to use hierarchical modeling in genetic epidemiologic studies with multiple markers to control overestimation of effects and potential false-positive associations. Methods: The data were first analyzed with the conventional approach of estimating each main effect individually. We subsequently employed hierarchical modeling by adding a second stage (prior) model that incorporated information on the potential function of the genes. We used an empirical-Bayes approach, estimating the residual effects of the genes from the data. When the residual effect was set to zero, we instead used a semi-Bayes approach, in which they were pre-specified. We also explored the impact of using different second-stage design matrices. Finally, we used two approaches for assessing gene-environment interactions. The first approach added product terms into the first-stage model. The second approach used three indicators for subjects exposed to gene-only, environment-only, and both genetic and environmental factors. Results: By pre-specifying the prior second-stage covariates, the estimates were shrunk to the mean of each pathway. The conventional model detected a number of positive associations, which were reduced with the hierarchical model. For example, the odds ratio for myeloperoxidase (G/G, G/A) genotype changed from 3.17 [95% confidence interval (CI), 1.32-7.59] to 1.64 (95% CI, 0.81-3.34). A similar phenomenon was observed for the gene-environment interactions. The odds ratio for the gene-environment interaction between tobacco smoking and N-acetyltransferase 1 fast genotype was 2.74 (95% CI, 0.68-11.0) from the conventional analysis and 1.24 (95% CI, 0.80-1.93) from the hierarchical model. Conclusion: Adding a second-stage hierarchical modeling can reduce the likelihood of false positive via shrinkage toward the prior mean, improve the risk estimation by increasing the precision, and, therefore, represents an alternative to conventional methods for genetic association studies.
Key Words: hierarchical model genetic polymorphism gene-environment interaction
This article has been cited by other articles:
![]() |
M. Y. Park and T. Hastie Penalized logistic regression for detecting gene interactions Biostat., January 1, 2008; 9(1): 30 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Hung, M. Baragatti, D. Thomas, J. McKay, N. Szeszenia-Dabrowska, D. Zaridze, J. Lissowska, P. Rudnai, E. Fabianova, D. Mates, et al. Inherited Predisposition of Lung Cancer: A Hierarchical Modeling Approach to DNA Repair and Cell Cycle Control Pathways Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2736 - 2744. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Ulrich, H. F. Nijhout, and M. C. Reed Mathematical modeling: epidemiology meets systems biology. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 827 - 829. [Full Text] [PDF] |
||||
![]() |
D. C. Thomas Are We Ready for Genome-wide Association Studies? Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 595 - 598. [Full Text] [PDF] |
||||
![]() |
D. C. Thomas The Need for a Systematic Approach to Complex Pathways in Molecular Epidemiology Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 557 - 559. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |